Stock Market & Financial Investment News

News Breaks September 6, 2012 06:15 EDT BIOC, ISIS Isis Pharmaceuticals expands use of BioClinica Express EDC BioClinica (BIOC) announced that Isis Pharmaceuticals (ISIS) will expand its current use of BioClinica's Express Electronic Data Capture solution to several upcoming trials. Isis has used BioClinica's Express EDC for previous drug studies and, after evaluating competing options, decided to expand its use of Express EDC to a broader range of clinical trials. News For BIOC;ISIS From The Last 14 Days Check below for free stories on BIOC;ISIS the last two weeks. Sign up for a free trial to see the rest of the stories you've been missing. May 20, 2013 07:34 EDT ISIS UBS to host a conference Subscribe for More Information May 9, 2013 16:59 EDT ISIS Isis Pharmaceuticals earns $3.5M from Biogen Subscribe for More Information 11:15 EDT ISIS High option volume stocks: BKS ISIS BRY GMCR JOE 06:16 EDT ISIS Isis Pharmaceuticals 9M share Secondary priced at $19.00 Subscribe for More Information May 7, 2013 16:35 EDT ISIS Isis Pharmaceuticals reports Q1 EPS (2c), consensus (2c) Subscribe for More Information 16:05 EDT ISIS Isis Pharmaceuticals files to sell common stock, no amount given Sign up for a free trial to see the rest of the stories you've been missing.